2014-01-29 12:51:02 - Physician Views: Will Generic Copaxone have Traction in the MS Market Given Emergence of Oral Therapies? - a new market research report on companiesandmarkets.com
Reasons to Buy
This week´s Physician Views poll will ask US-based neurologists:
- What percentage of Copaxone patients they anticipate switching to a three-times weekly formulation
- Whether a three-times weekly formulation will have much impact on oral switching trends
- What percentage of Copaxone patients they expect to switch to an oral therapy over the next 12 months
- What type of pricing discount they anticipate necessary to drive uptake of a generic Copaxone product
- Whether they believe it ethical to require generic Copaxone to be used as a first-line therapy in relapsing, remitting MS patients?
Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Company Profile Reports
Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.